Drugplain

EXPECTORANT GUAIFENESIN EXTENDED-RELEASE 1200 mg/1

GUAIFENESIN · TABLET · YET HEALTH GROUP LLC

No Recall History
Plain English

EXPECTORANT GUAIFENESIN EXTENDED-RELEASE is a tablet containing guaifenesin at 1200 mg/1, taken oral. Manufactured by YET HEALTH GROUP LLC.

Key Facts

Brand Name
EXPECTORANT GUAIFENESIN EXTENDED-RELEASE
Generic Name
GUAIFENESIN
NDC Code (Product)
81179-007
Manufacturer
YET HEALTH GROUP LLC
Strength
1200 mg/1
Dosage Form
TABLET
Route
ORAL
Marketing Status
Application #
ANDA213420
Drug Class
Expectorant [EPC]
Marketing Start
04/05/2021

Recall History

No Recall History

Frequently Asked Questions

What is EXPECTORANT GUAIFENESIN EXTENDED-RELEASE used for?

EXPECTORANT GUAIFENESIN EXTENDED-RELEASE contains GUAIFENESIN. It is a tablet taken oral. Consult your doctor for specific uses.

Is EXPECTORANT GUAIFENESIN EXTENDED-RELEASE a controlled substance?

EXPECTORANT GUAIFENESIN EXTENDED-RELEASE is not classified as a controlled substance by the DEA.

What is the generic name for EXPECTORANT GUAIFENESIN EXTENDED-RELEASE?

The generic name for EXPECTORANT GUAIFENESIN EXTENDED-RELEASE is GUAIFENESIN. There are 12 other brand versions of GUAIFENESIN.

What is the NDC code for EXPECTORANT GUAIFENESIN EXTENDED-RELEASE 1200 mg/1?

The NDC (National Drug Code) for EXPECTORANT GUAIFENESIN EXTENDED-RELEASE 1200 mg/1 is 81179-007, listed by YET HEALTH GROUP LLC.